The nuclear export protein XPO1—from biology to targeted therapy

AS Azmi, MH Uddin, RM Mohammad - Nature reviews Clinical oncology, 2021 - nature.com
Abstract Exportin 1 (XPO1), also known as chromosome region maintenance protein 1,
plays a crucial role in maintaining cellular homeostasis via the regulated export of a range of …

Update on mantle cell lymphoma

K Maddocks - Blood, The Journal of the American Society of …, 2018 - ashpublications.org
Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma that is most
commonly treated with combination chemo-immunotherapy at diagnosis because of the …

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

P Jares, D Colomer, E Campo - Nature Reviews Cancer, 2007 - nature.com
Mantle cell lymphoma (MCL) is a well-defined lymphoid malignancy characterized by a
rapid clinical evolution and poor response to current therapeutic protocols. The genetic and …

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

P Pérez-Galán, G Roué, N Villamor, E Montserrat… - Blood, 2006 - ashpublications.org
Mantle-cell lymphoma (MCL) is a mature B-cell lymphoma with an aggressive course and
generally poor prognosis. Conventional chemotherapy has little efficacy. Bortezomib is a …

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

B Nachmias, Y Ashhab, D Ben-Yehuda - Seminars in cancer biology, 2004 - Elsevier
Apoptosis is a crucial biological process that prevents uncontrolled cell proliferation and
eliminates harmful cells. Resistance to apoptotic stimuli is a hallmark feature of various …

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

S Zhang, VC Jiang, G Han, D Hao, J Lian, Y Liu… - Nature …, 2021 - nature.com
The mechanisms driving therapeutic resistance and poor outcomes of mantle cell lymphoma
(MCL) are incompletely understood. We characterize the cellular and molecular …

Survivin as a target for new anticancer interventions

N Zaffaroni, M Pannati… - Journal of cellular and …, 2005 - Wiley Online Library
Survivin is a member of the inhibitor of apoptosis protein (IAP) family, that has been
implicated in both control of cell division and inhibition of apoptosis. Specifically, its anti …

Nuclear or cytoplasmic expression of survivin: what is the significance?

F Li, J Yang, N Ramnath, MM Javle… - International journal of …, 2005 - Wiley Online Library
Growing evidence suggests that survivin expression in cancer cell nuclei may represent an
important prognostic marker to predict disease outcome for cancer patients. Current reports …

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis

X He, Z Chen, T Fu, X Jin, T Yu, Y Liang, X Zhao… - BMC cancer, 2014 - Springer
Background Ki-67 is a nuclear protein involved in cell proliferation regulation, and its
expression has been widely used as an index to evaluate the proliferative activity of …

Survivin is an independent prognostic marker for risk stratification of breast cancer patients

PN Span, FCGJ Sweep, ETG Wiegerinck… - Clinical …, 2004 - academic.oup.com
Background: Results in previous qualitative studies of the association of the apoptosis
inhibitor survivin with prognosis of breast cancer patients have been contradictory. Methods …